1-2 of 2
Adrienne Groman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL

Clinical Trials & Observations
Pallawi Torka, Adrienne Groman, Jerry Wong, Jenna Nichols, Angela Kader, Cory Mavis, Andrea Anampa-Guzmán, Sheila Jani Sait, AnneMarie Block, Eugene Przespolewski, Alice Mohr, Ian Lund, Kenneth McWhite, Jessica Kostrewa, Joseph DeMarco, Michael Johnson, Andrea Darrall, Roshneke Thomas, Suchitra Sundaram, Paola Ghione, Alan Hutson, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1146–1155.
https://doi.org/10.1182/bloodadvances.2022008543
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Clinical Trials & Observations
Pallawi Torka, Shalin K. Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros, Emily C. Ayers, Daniel J. Landsburg, David A. Bond, Kami J. Maddocks, Anshu Giri, Brian Hess, Luu Q. Pham, Ranjana Advani, Yang Liu, Stefan Klaus Barta, Julie M. Vose, Michael C. Churnetski, Jonathon B. Cohen, Madelyn Burkart, Reem Karmali, Joanna Zurko, Amitkumar Mehta, Adam J. Olszewski, Sarah Lee, Brian T. Hill, Timothy F. Burns, Frederick Lansigan, Emma Rabinovich, David Peace, Adrienne Groman, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2020) 4 (2): 253–262.
https://doi.org/10.1182/bloodadvances.2019000875
Published: 2020